Top Markets
#1 DogBull DogBull +108.89%
#2 Siacoin Siacoin +62.61%
#3 MarsCoin MarsCoin +56.44%
#4 ADO Protocol ADO Protocol +52.97%
#5 The Bitcoin Bull The Bitcoin Bull +32.78%
#6 Ontology Gas Ontology Gas +19.78%
#7 Akedo Akedo +12.83%
#8 Arowana Arowana +11.61%
#9 UnifAI Network UnifAI Network +11.46%
#10 Cash Cat Cash Cat +11.11%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Classement en actions #15118
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Prix de l'action
$4.74
Dernière synchronisation: 2026-08-31
Capitalisation boursière
$372.19M
Changement (1 jour)
-2.47%
Changement (1 an)
-1.04%
Pays
US
Échange Lexeo Therapeutics, Inc. Common Stock (LXEO)

Catégorie

Healthcare
Le prix LXEO avec la capitalisation boursière de B
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
LXEO
$4.74
Capitalisation boursière de Lexeo Therapeutics, Inc. Common Stock(LXEO)
Capitalisation boursière: $372.19M
En September 2026, Lexeo Therapeutics, Inc. Common Stock a une capitalisation boursière de $372.19M. Cela fait de Lexeo Therapeutics, Inc. Common Stock la 15118th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Lexeo Therapeutics, Inc. Common Stock du 2023 au 2026
LXEO par rapport au top 5 des plus populaires stocks
Prix pour LXEO L’actif B La capitalisation boursière de B Résultats
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$67,838.67 $372.19M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.327T +1,431,095.66%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$59,154.10 $372.19M
Apple Inc. Apple Inc.
AAPL
$4.645T +1,247,876.74%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$51,836.16 $372.19M
Alphabet Inc. Alphabet Inc.
GOOG
$4.070T +1,093,489.98%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$48,197.93 $372.19M
Microsoft Corporation Microsoft Corporation
MSFT
$3.785T +1,016,733.97%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$35,533.17 $372.19M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.790T +749,545.01%